Breaking News Instant updates and real-time market news.

SGA

Saga Communications

$25.43 /

+ (+0.00%)

16:16
06/18/20
06/18
16:16
06/18/20
16:16

Saga Communications temporarily suspends quarterly dividend

Saga Communications announced that its Board of Directors is temporarily suspending the quarterly cash dividend in response to the continued economic uncertainty of the impact of COVID-19. Additional actions being taken to conserve the company's cash position include reducing planned capital spending and seeking discounts from vendors. By preserving the company's cash position, the company believes market conditions may present attractive acquisition opportunities. The company will consider the resumption of quarterly cash dividends in the near future as economic conditions permit.

TODAY'S FREE FLY STORIES

Initiation
SilverCrest Metals initiated with a Hold at Stifel » 07:49
07/06/20
07/06
07:49
07/06/20
07:49
SILV

SilverCrest Metals

$9.04 /

-0.015 (-0.17%)

Stifel GMP analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SILV SilverCrest Metals
$9.04 /

-0.015 (-0.17%)

SILV SilverCrest Metals
$9.04 /

-0.015 (-0.17%)

05/29/20 BMO Capital
SilverCrest Metals price target raised to C$13 from C$10.25 at BMO Capital
03/30/20 RBC Capital
SilverCrest Metals price target raised to C$11 from C$9.50 at RBC Capital
03/03/20 B. Riley FBR
SilverCrest Metals upgraded to Buy after selloff at B. Riley FBR
03/03/20 B. Riley FBR
SilverCrest Metals upgraded to Buy from Neutral at B. Riley FBR
Recommendations
Pacira price target raised to $64 from $52 at Needham » 07:47
07/06/20
07/06
07:47
07/06/20
07:47
PCRX

Pacira

/

+

, HRTX

Heron Therapeutics

$15.51 /

-0.54 (-3.36%)

Needham analyst Serge…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
/

+

HRTX Heron Therapeutics
$15.51 /

-0.54 (-3.36%)

PCRX Pacira
/

+

06:02 Today Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
06/30/20 SVB Leerink
Heron Therapeutics price target lowered to $19 from $26 at SVB Leerink
HRTX Heron Therapeutics
$15.51 /

-0.54 (-3.36%)

07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
06/30/20 SVB Leerink
Heron Therapeutics price target lowered to $19 from $26 at SVB Leerink
06/30/20 Northland
Northland keeps Outperform on Heron Therapeutics after 'minor setback'
PCRX Pacira
/

+

HRTX Heron Therapeutics
$15.51 /

-0.54 (-3.36%)

  • 04
    Oct
PCRX Pacira
/

+

HRTX Heron Therapeutics
$15.51 /

-0.54 (-3.36%)

Recommendations
Innovative Industrial Properties price target raised to $120 from $110 at Roth Capital » 07:47
07/06/20
07/06
07:47
07/06/20
07:47
IIPR

Innovative Industrial Properties

$93.00 /

-1.01 (-1.07%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IIPR Innovative Industrial Properties
$93.00 /

-1.01 (-1.07%)

IIPR Innovative Industrial Properties
$93.00 /

-1.01 (-1.07%)

06/23/20 Ladenburg
Innovative Industrial Properties price target raised to $104 from $83.50 at Ladenburg
05/21/20 Compass Point
Innovative Industrial price target raised to $100 from $75 at Compass Point
05/06/20 Ladenburg
Innovative Industrial price target raised to $83.50 from $69.50 at Ladenburg
03/23/20 Ladenburg
Innovative Industrial Properties upgraded to Buy from Neutral at Ladenburg
IIPR Innovative Industrial Properties
$93.00 /

-1.01 (-1.07%)

  • 30
    Jun
  • 27
    May
  • 24
    Jan
  • 12
    Jul
IIPR Innovative Industrial Properties
$93.00 /

-1.01 (-1.07%)

Initiation
MAG Silver initiated with a Buy at Stifel » 07:47
07/06/20
07/06
07:47
07/06/20
07:47
MAG

MAG Silver

$13.72 /

-0.31 (-2.21%)

Stifel analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAG MAG Silver
$13.72 /

-0.31 (-2.21%)

MAG MAG Silver
$13.72 /

-0.31 (-2.21%)

05/05/20 BMO Capital
MAG Silver price target raised to C$18 from C$17 at BMO Capital
04/28/20 TD Securities
MAG Silver price target raised to C$22 from C$19.50 at TD Securities
Initiation
Bear Creek Mining initiated with a Buy at Stifel » 07:46
07/06/20
07/06
07:46
07/06/20
07:46
BCEKF

Bear Creek Mining

$0.00 /

+ (+0.00%)

Stifel GMP analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Theratechnologies presents data from ibalizumab study at AIDS conference » 07:46
07/06/20
07/06
07:46
07/06/20
07:46
THTX

Theratechnologies

$1.98 /

+ (+0.00%)

Theratechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$1.98 /

+ (+0.00%)

THTX Theratechnologies
$1.98 /

+ (+0.00%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$1.98 /

+ (+0.00%)

Initiation
Aimia initiated with a Buy at Jefferies » 07:44
07/06/20
07/06
07:44
07/06/20
07:44
GAPFF

Aimia

$0.00 /

+ (+0.00%)

Jefferies analyst Hamzah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GAPFF Aimia
$0.00 /

+ (+0.00%)

05/13/20 TD Securities
Aimia price target raised to C$4 from C$3.25 at TD Securities
05/13/20 RBC Capital
Aimia upgraded to Outperform from Sector Perform at RBC Capital
04/30/20 RBC Capital
Aimia price target lowered to C$5 from C$6 at RBC Capital
01/14/20 TD Securities
Aimia upgraded to Buy from Hold at TD Securities
Recommendations
Evergy price target raised to $66 from $60 at Wells Fargo » 07:43
07/06/20
07/06
07:43
07/06/20
07:43
EVRG

Evergy

$61.38 /

+0.385 (+0.63%)

Wells Fargo analyst Sarah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVRG Evergy
$61.38 /

+0.385 (+0.63%)

EVRG Evergy
$61.38 /

+0.385 (+0.63%)

06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
02/03/20 JPMorgan
Evergy price target raised to $76 from $72 at JPMorgan
01/22/20 SunTrust
Evergy price target raised to $73 from $69 at SunTrust
EVRG Evergy
$61.38 /

+0.385 (+0.63%)

EVRG Evergy
$61.38 /

+0.385 (+0.63%)

Periodicals
WhatsApp pauses processing Hong Kong requests for user data, WSJ reports » 07:42
07/06/20
07/06
07:42
07/06/20
07:42
FB

Facebook

$233.46 /

-4.02 (-1.69%)

WhatsApp is pausing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$233.46 /

-4.02 (-1.69%)

FB Facebook
$233.46 /

-4.02 (-1.69%)

07/01/20 Monness Crespi
Facebook has opportunity to emerge from crisis stronger, says Monness Crespi
07/01/20 Goldman Sachs
Facebook checks show limited impact from ad boycott, says Goldman Sachs
06/30/20 Morgan Stanley
Morgan Stanley says buy Facebook amid boycott-driven weakness
06/30/20 Citi
Facebook shares overreacting to pause in ad spending, says Citi
FB Facebook
$233.46 /

-4.02 (-1.69%)

FB Facebook
$233.46 /

-4.02 (-1.69%)

FB Facebook
$233.46 /

-4.02 (-1.69%)

FB Facebook
$233.46 /

-4.02 (-1.69%)

Initiation
Translate Bio initiated with an Outperform at William Blair » 07:41
07/06/20
07/06
07:41
07/06/20
07:41
TBIO

Translate Bio

$17.89 /

+0.42 (+2.40%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TBIO Translate Bio
$17.89 /

+0.42 (+2.40%)

TBIO Translate Bio
$17.89 /

+0.42 (+2.40%)

06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
06/26/20 Citi
Translate Bio price target raised to $35 from $17 at Citi
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
06/25/20 Citi
Translate Bio price target raised to $35 from $17 at Citi
TBIO Translate Bio
$17.89 /

+0.42 (+2.40%)

  • 26
    Jun
  • 18
    Sep
TBIO Translate Bio
$17.89 /

+0.42 (+2.40%)

TBIO Translate Bio
$17.89 /

+0.42 (+2.40%)

Recommendations
Netflix content leadership poised to persist, says Canaccord » 07:41
07/06/20
07/06
07:41
07/06/20
07:41
NFLX

Netflix

$476.31 /

-9.47 (-1.95%)

Canaccord analyst Maria…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

04:58 Today Imperial Capital
Netflix downgraded to In-Line from Outperform at Imperial Capital
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/30/20 Cowen
Netflix price target raised to $535 from $485 at Cowen
06/23/20 JPMorgan
Netflix user growth implies upside to Q2 guidance, says JPMorgan
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

Hot Stocks
GAP Airports reports June traffic down 76.8% year-over-year » 07:40
07/06/20
07/06
07:40
07/06/20
07:40
PAC

GAP Airports

$74.20 /

+1.14 (+1.56%)

GAP Airports announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAC GAP Airports
$74.20 /

+1.14 (+1.56%)

PAC GAP Airports
$74.20 /

+1.14 (+1.56%)

06/10/20 BofA
GAP Airports downgraded to Neutral from Buy at BofA
06/10/20 BofA
GAP Airports downgraded to Neutral from Buy at BofA
04/08/20 Goldman Sachs
GAP Airports upgraded to Buy from Sell at Goldman Sachs
04/08/20 UBS
GAP Airports upgraded to Buy from Neutral at UBS
PAC GAP Airports
$74.20 /

+1.14 (+1.56%)

General news
Treasury Market Outlook: global stocks are surging and are in full risk-on mode » 07:40
07/06/20
07/06
07:40
07/06/20
07:40

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Zoom Video price target raised to $300 from $230 at Baird » 07:38
07/06/20
07/06
07:38
07/06/20
07:38
ZM

Zoom Video

$261.71 /

+2.48 (+0.96%)

Baird analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZM Zoom Video
$261.71 /

+2.48 (+0.96%)

ZM Zoom Video
$261.71 /

+2.48 (+0.96%)

06/24/20 Goldman Sachs
Zoom Video price target raised to $187 from $154 at Goldman Sachs
06/05/20 JPMorgan
DocuSign price target raised to $150 from $90 at JPMorgan
06/05/20 DA Davidson
Slack Technologies price target raised to $32 from $29 at DA Davidson
06/04/20 DA Davidson
Logitech price target raised to $70 from $64 at DA Davidson
ZM Zoom Video
$261.71 /

+2.48 (+0.96%)

ZM Zoom Video
$261.71 /

+2.48 (+0.96%)

ZM Zoom Video
$261.71 /

+2.48 (+0.96%)

ZM Zoom Video
$261.71 /

+2.48 (+0.96%)

Hot Stocks
Tradeweb Markets reports ADV of $780.9B in June, $778.4B in Q2 » 07:38
07/06/20
07/06
07:38
07/06/20
07:38
TW

Tradeweb Markets

$58.30 /

-0.91 (-1.54%)

Tradeweb Markets reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TW Tradeweb Markets
$58.30 /

-0.91 (-1.54%)

TW Tradeweb Markets
$58.30 /

-0.91 (-1.54%)

06/22/20 Goldman Sachs
Tradeweb Markets downgraded to Neutral from Buy at Goldman Sachs
06/15/20 Piper Sandler
Tradeweb Markets price target raised to $63 from $50 at Piper Sandler
05/08/20 Barclays
Tradeweb Markets price target raised to $60 from $53 at Barclays
04/21/20 Rosenblatt
Tradeweb Markets' set-up remains attractive, says Rosenblatt
TW Tradeweb Markets
$58.30 /

-0.91 (-1.54%)

  • 23
    Apr
  • 18
    Oct
TW Tradeweb Markets
$58.30 /

-0.91 (-1.54%)

TW Tradeweb Markets
$58.30 /

-0.91 (-1.54%)

Recommendations
Ryder price target raised to $47 from $37 at Baird » 07:35
07/06/20
07/06
07:35
07/06/20
07:35
R

Ryder

$36.84 /

+0.53 (+1.46%)

Baird analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
R Ryder
$36.84 /

+0.53 (+1.46%)

R Ryder
$36.84 /

+0.53 (+1.46%)

04/01/20 Mizuho
Bristol-Myers Squibb CVR price target raised to $6.17 from $4.52 at Mizuho
03/27/20 Wolfe Research
Ryder downgraded to Peer Perform from Outperform at Wolfe Research
03/23/20 SunTrust
SunTrust lowers price targets in Trucking and Logistics segment
03/10/20 Stifel
Ryder upgraded to Buy from Hold at Stifel
R Ryder
$36.84 /

+0.53 (+1.46%)

R Ryder
$36.84 /

+0.53 (+1.46%)

Hot Stocks
Apollo Global forms new origination platform » 07:35
07/06/20
07/06
07:35
07/06/20
07:35
APO

Apollo Global

$49.87 /

-0.34 (-0.68%)

Apollo Global announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APO Apollo Global
$49.87 /

-0.34 (-0.68%)

APO Apollo Global
$49.87 /

-0.34 (-0.68%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
APO Apollo Global
$49.87 /

-0.34 (-0.68%)

  • 26
    Nov
APO Apollo Global
$49.87 /

-0.34 (-0.68%)

APO Apollo Global
$49.87 /

-0.34 (-0.68%)

APO Apollo Global
$49.87 /

-0.34 (-0.68%)

Hot Stocks
Bellus sinks 78% to $2.80 after Phase 2 chronic cough failure  07:33
07/06/20
07/06
07:33
07/06/20
07:33
BLU

Bellus Health

$12.01 /

+0.21 (+1.78%)

 
ShowHide Related Items >><<
BLU Bellus Health
$12.01 /

+0.21 (+1.78%)

BLU Bellus Health
$12.01 /

+0.21 (+1.78%)

06/26/20 H.C. Wainwright
Bellus Health initiated with a Buy at H.C. Wainwright
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
09/30/19
Fly Intel: Top five analyst initiations
09/30/19 Jefferies
Jefferies sees potential double in Bellus Health, starts shares at Buy
  • 05
    Sep
Hot Stocks
Abbott receives FDA approval for next-generation Gallant ICD, CRT-D devices » 07:32
07/06/20
07/06
07:32
07/06/20
07:32
ABT

Abbott

$92.25 /

+0.64 (+0.70%)

Abbott announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$92.25 /

+0.64 (+0.70%)

ABT Abbott
$92.25 /

+0.64 (+0.70%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
ABT Abbott
$92.25 /

+0.64 (+0.70%)

ABT Abbott
$92.25 /

+0.64 (+0.70%)

ABT Abbott
$92.25 /

+0.64 (+0.70%)

ABT Abbott
$92.25 /

+0.64 (+0.70%)

Hot Stocks
ADC Therapeutics announces FDA lifts partial hold on camidanlumab tesirine trial » 07:32
07/06/20
07/06
07:32
07/06/20
07:32
ADCT

ADC Therapeutics

$52.61 /

+3.36 (+6.82%)

ADC Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADCT ADC Therapeutics
$52.61 /

+3.36 (+6.82%)

ADCT ADC Therapeutics
$52.61 /

+3.36 (+6.82%)

06/09/20 Morgan Stanley
ADC Therapeutics initiated with an Overweight at Morgan Stanley
06/09/20 Cowen
ADC Therapeutics initiated with an Outperform at Cowen
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
  • 15
    May
  • 03
    Oct
Initiation
Venus Concept initiated with a Buy at BTIG » 07:32
07/06/20
07/06
07:32
07/06/20
07:32
VERO

Venus Concept

$3.53 /

+0.32 (+9.97%)

BTIG analyst Marie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERO Venus Concept
$3.53 /

+0.32 (+9.97%)

VERO Venus Concept
$3.53 /

+0.32 (+9.97%)

05:48 Today BTIG
Venus Concept initiated with a Buy at BTIG
03/31/20
Fly Intel: Top five analyst downgrades
03/31/20 Oppenheimer
Venus Concept downgraded to Perform at Oppenheimer as COVID-19 clouds outlook
03/31/20 Oppenheimer
Venus Concept downgraded to Perform from Outperform at Oppenheimer
VERO Venus Concept
$3.53 /

+0.32 (+9.97%)

VERO Venus Concept
$3.53 /

+0.32 (+9.97%)

Downgrade
Cooper Companies downgraded to Neutral, Baird see confluence of issues » 07:30
07/06/20
07/06
07:30
07/06/20
07:30
COO

Cooper Companies

$288.84 /

+1.505 (+0.52%)

, JNJ

Johnson & Johnson

$141.01 /

+0.755 (+0.54%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

JNJ Johnson & Johnson
$141.01 /

+0.755 (+0.54%)

COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

05:19 Today Baird
Cooper Companies downgraded to Neutral from Outperform at Baird
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/26/20 Stephens
Cooper Companies price target raised to $325 from $300 at Stephens
05/26/20 KeyBanc
Cooper Companies price target lowered to $330 from $380 at KeyBanc
JNJ Johnson & Johnson
$141.01 /

+0.755 (+0.54%)

07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

JNJ Johnson & Johnson
$141.01 /

+0.755 (+0.54%)

JNJ Johnson & Johnson
$141.01 /

+0.755 (+0.54%)

COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

JNJ Johnson & Johnson
$141.01 /

+0.755 (+0.54%)

JNJ Johnson & Johnson
$141.01 /

+0.755 (+0.54%)

Initiation
Vroom initiated with a Neutral at BofA » 07:27
07/06/20
07/06
07:27
07/06/20
07:27
VRM

Vroom

$54.21 /

+0.045 (+0.08%)

BofA analyst Nat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$54.21 /

+0.045 (+0.08%)

07:13 Today Wedbush
Vroom initiated with an Outperform at Wedbush
06:41 Today Stifel
Stifel starts Vroom at Buy, sees premium as justified
06:40 Today JMP Securities
Vroom initiated with an Outperform at JMP Securities
06:19 Today Wells Fargo
Vroom initiated with an Overweight at Wells Fargo
  • 09
    Jun
VRM Vroom
$54.21 /

+0.045 (+0.08%)

VRM Vroom
$54.21 /

+0.045 (+0.08%)

Initiation
Everest Re initiated with a Buy at BofA » 07:25
07/06/20
07/06
07:25
07/06/20
07:25
RE

Everest Re

$200.50 /

-3.565 (-1.75%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RE Everest Re
$200.50 /

-3.565 (-1.75%)

RE Everest Re
$200.50 /

-3.565 (-1.75%)

06:27 Today BofA
Everest Re initiated with a Buy at BofA
06/16/20 Wells Fargo
Wells Fargo upgrades Everest Re to Overweight on best market in 20 years
06/16/20 Wells Fargo
Everest Re upgraded to Overweight from Equal Weight at Wells Fargo
04/02/20 Keefe Bruyette
Everest Re upgraded to Outperform from Market Perform at Keefe Bruyette
RE Everest Re
$200.50 /

-3.565 (-1.75%)

RE Everest Re
$200.50 /

-3.565 (-1.75%)

Hot Stocks
Bellus Phase 2 chronic cough trial did not achieve statistical significance » 07:25
07/06/20
07/06
07:25
07/06/20
07:25
BLU

Bellus Health

$12.01 /

+0.21 (+1.78%)

Bellus Health announced…

Bellus Health announced topline results from its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough. The trial did not achieve statistical significance for the primary endpoint of reduction in placebo-adjusted cough frequency at any dose tested, the company said. A clinically meaningful and highly statistically significant placebo-adjusted reduction in cough frequency was achieved in a pre-specified sub-group of high cough count patients, it added. BLU-5937 was also observed to be well tolerated with no serious adverse events reported and no withdrawals due to treatment-related adverse events at any dose, according to Bellus. "In the RELIEF trial, we observed data that we believe is competitive within the P2X3 class, including the reduction in cough frequency shown in patients with higher cough counts and a low taste effect. While we had hoped to see more response in the lower cough patients, BLU-5937 and other P2X3 antagonists may have the most benefit in patients with a greater disease burden," said Roberto Bellini, CEO of Bellus. "We believe the Phase 2 data support moving BLU-5937 forward into an adaptive Phase 2b trial enriched for higher cough count patients. We expect to begin this trial in the fourth quarter of 2020."

ShowHide Related Items >><<
BLU Bellus Health
$12.01 /

+0.21 (+1.78%)

BLU Bellus Health
$12.01 /

+0.21 (+1.78%)

06/26/20 H.C. Wainwright
Bellus Health initiated with a Buy at H.C. Wainwright
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
09/30/19
Fly Intel: Top five analyst initiations
09/30/19 Jefferies
Jefferies sees potential double in Bellus Health, starts shares at Buy
  • 05
    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.